RUOLO DEI BIOMARCATORI NELLA COLITE ULCEROSA. LE NUOVE LINEE GUIDA AGA. INSERITE ANCHE LA LATTOFERRINA FECALE! DA ” GASTROENTEROLOGY” (FREE)

GASTROENTEROLOGIA, IBD, LINEE GUIDA EBM, MEDICINA INTERNA, Senza categoria

AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis Siddharth Singh et al. Background & Aims Biomarkers are used frequently for noninvasive monitoring and treatment decision making in the management of patients with ulcerative colitis (UC). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions…

MALATTIA DI CROHN. LE LINEE GUIDA DEL GRUPPO IG-IBD APPENA USCITE! DA “Digestive and Liver Disease” (FREE)

GASTROENTEROLOGIA, IBD, LINEE GUIDA EBM, Senza categoria

Use of biologics for the management of Crohn’s disease: IG-IBD clinical guidelines based on the GRADE methodology FABIO MACALUSO ED Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) Abstract A cure for Crohn’s disease (CD), a chronic inflammatory disease of the gastrointestinal tract of unknown etiology, is not available, so patients require lifelong…

ONDANSETRON PER IL COLON IRRITABILE – DIARREA: IL TRIAL TRITON + META-ANALISI. BREAKING NEWS DA “ALIMENTARY PHARM & THERAP”

GASTROENTEROLOGIA, IBS, MEDICI DI FAMIGLIA, MEDICINA INTERNA, Senza categoria

Randomised, Placebo-controlled Trial and Meta-analysis Show Benefit of Ondansetron for Irritable Bowel Syndrome with Diarrhoea: The TRITON Trial Gunn, David et al. Abstract Ondansetron may be beneficial in irritable bowel syndrome with diarrhoea (IBS-D). Aim: To conduct a 12-week parallel group, randomised, double-blind, placebo-controlled trial of ondansetron 4mg o.d. (titrated up to 8mg t.d.s.) in…

ENCEFALOPATIA EPATICA: UNA GRANDE META-ANALISI 2022 DALLA PARTE DEL PAZIENTE! LATTULOSIO O RIFAXIMINA? DA “AMERICAN JOURNAL OF GASTROENTEROLOGY”

CIRROSI EPATICA, EPATOLOGIA, GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNA, Senza categoria

Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy Andrew M. Moon et al INTRODUCTION: Patients with hepatic encephalopathy (HE) suffer from significant symptoms and impaired quality of life. Improved understanding on the potential benefits of first-line HE therapies may aid patientprovider discussions regarding expected benefits of…

LIVELLI EMATICI DI ENDOTOSSINA: BIOMARCATORI DELLA PROGRESSIONE DELLA NASH. UNA IMPEGNATIVA META-ANALISI DA “CLINICAL GASTROENTEROLOGY & HEPATOLOGY” (FREE).

EPATOLOGIA, GASTROENTEROLOGIA, MEDICINA DEI PROBIOTICI, NUTRIZIONE, Senza categoria

Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis Josefin Soppert et al. Abstract Background and Aims: Growing evidence supports a role of gut-derived metabolitesin non-alcoholic fatty liver disease (NAFLD), but the relation of endotoxin levels with gut permeability and NAFLD stage remains unclear. This systematic review with meta-…

E’ UTILE IL NUOVO TRIAL? UN NUOVO TOOL PER EVITARE SPRECHI NELLA RICERCA ! ABBIAMO DA IMPARARE DAI GINECOLOGY! MA IOANNIDIS COLPISCE ANCORA ! DA”BJOG” (FREE).

CHIRURGIA, EPATOLOGIA, GASTROENTEROLOGIA, MEDICINA INTERNA, METODOLOGIA, REAL WORLD EVIDENCE, Senza categoria

Assessing the usefulness of randomized trials in obstetrics and gynaecology Janneke van ‘t Hooft et al. Health care professionals will be familiar with how little of what they read in medical journals is of direct value (useful) to their practice.(1) Randomized controlled trials (RCTs) are traditionally at the top of the evidence validity hierarchy for…